Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Immunogenicity of an EV71 Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy, safety, and immunogenicity of an EV71 vaccine completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterovirus 71 Infection

Drugs mentioned

• EV71 vaccine (enterovirus 71 vaccine)

Snippet

Sponsor: Medigen Vaccine Biologics Corp. | Conditions: Enterovirus 71 Infection | Phase 3 | Status: COMPLETED